{
  "name" : "dacemirror.sci-hub.se_journal-article_e7632383230a398994a5f2dc7f6d4be5_chen2018.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Functional Multichannel Poly(Propylene Fumarate)-Collagen Scaffold with Collagen-Binding Neurotrophic Factor 3 Promotes Neural Regeneration After Transected Spinal Cord Injury",
    "authors" : [ "Xi Chen", "Yannan Zhao", "Xing Li", "Zhifeng Xiao", "Yuanjiang Yao", "Yun Chu", "Balázs Farkas", "Ilaria Romano", "Fernando Brandi", "Jianwu Dai" ],
    "emails" : [ "jwdai@genetics.ac.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "www.advhealthmat.de\nFULL PAPER\n1800315 (1 of 13) © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim"
    }, {
      "heading" : "Functional Multichannel Poly(Propylene Fumarate)-Collagen",
      "text" : ""
    }, {
      "heading" : "Scaffold with Collagen-Binding Neurotrophic Factor 3",
      "text" : ""
    }, {
      "heading" : "Promotes Neural Regeneration After Transected Spinal",
      "text" : "Cord Injury"
    }, {
      "heading" : "Xi Chen, Yannan Zhao, Xing Li, Zhifeng Xiao, Yuanjiang Yao, Yun Chu, Balázs Farkas,",
      "text" : ""
    }, {
      "heading" : "Ilaria Romano, Fernando Brandi,* and Jianwu Dai*",
      "text" : "DOI: 10.1002/adhm.201800315\n1. Introduction\nSpinal cord injury (SCI) is a severe and irreversible central nervous system (CNS) injury with varying degrees of damage and loss of motor and sensory functions below the injury level.[1] Numerous mechanisms underlie the deficient axonal regrowth and poor functional recovery that occur postSCI, including an absence of neurotrophic factors to protect neurons and to stimulate intrinsic neuronal regeneration-related responses,[2] the lack of growth-permissive substrates to support axon elongation through the lesion area,[3] the production of various myelin-associated and extracellular matrix-derived inhibitory molecules including Nogo, oligodendrocyte myelin glycoprotein (OMgp), and chondroitin sulfate proteoglycans (CSPGs),[4] and the occurrence of a range of secondary effects including vascular damage, scar formation, and inflammation.[4a,5] Given that even apparently minor displacement of spinal tissue can result in severing of axons and loss of function, the Many factors contribute to the poor axonal regrowth and ineffective functional recovery after spinal cord injury (SCI). Biomaterials have been used for SCI repair by promoting bridge formation and reconnecting the neural tissue at the lesion site. The mechanical properties of biomaterials are critical for successful design to ensure the stable support as soon as possible when compressed by the surrounding spine and musculature. Poly(propylene fumarate) (PPF) scaffolds with high mechanical strength have been shown to provide firm spatial maintenance and to promote repair of tissue defects. A multichannel PPF scaffold is combined with collagen biomaterial to build a novel biocompatible delivery system coated with neurotrophin-3 containing an engineered collagen-binding domain (CBD-NT3). The parallel-aligned multichannel structure of PPF scaffolds guide the direction of neural tissue regeneration across the lesion site and promote reestablishment of bridge connectivity. The combinatorial treatment consisting of PPF and collagen loaded with CBD-NT3 improves the inhibitory microenvironment, facilitates axonal and neuronal regeneration, survival of various types of functional neurons and remyelination and synapse formation of regenerated axons following SCI. This novel treatment strategy for SCI repair effectively promotes neural tissue regeneration after transected spinal injury by providing a regrowth-supportive microenvironment and eventually induces functional improvement."
    }, {
      "heading" : "Poly(Propylene Fumarate) Scaffolds",
      "text" : "Dr. X. Chen, Prof. J. Dai Institute of Combined Injury State Key Laboratory of Trauma Burns and Combined Injury Chongqing Engineering Research Center for Nanomedicine Chongqing Engineering Research Center for Biomaterials and Regenerative Medicine College of Preventive Medicine Army Medical University (Third Military Medical University) 30th Gaotanyan street, Chongqing 400038, China E-mail: jwdai@genetics.ac.cn Dr. Y. Zhao, Dr. X. Li, Dr. Z. Xiao, Prof. J. Dai State Key Laboratory of Molecular Developmental Biology Institute of Genetics and Developmental Biology Chinese Academy of Sciences Beijing 100101, China Dr. Y. Yao, Prof. J. Dai Department of Neurobiology Chongqing Key Laboratory of Neurobiology Army Medical University (Third Military Medical University) 30th Gaotanyan street, Chongqing 400038, China Dr. Y. Chu Division of Nanobiomedicine Suzhou Institute of Nano-Tech and Nano-Bionics Chinese Academy of Sciences Suzhou 215123, China Dr. B. Farkas, Dr. I. Romano, Dr. F. Brandi Istituto Italiano di Tecnologia Via Morego 30, Genova 16163, Italy E-mail: fernando.brandi@ino.cnr.it Dr. F. Brandi Istituto Nazionale di Ottica Consiglio Nazionale delle Ricerche Via Moruzzi 1, Pisa 56124, ItalyThe ORCID identification number(s) for the author(s) of this article\ncan be found under https://doi.org/10.1002/adhm.201800315.\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (2 of 13)\ncomplex nature of SCI poses a significant challenge for clinical treatment.[6]\nVarious biomaterials have been used for promoting SCI repair. Biomaterials play therapeutic effects by providing a bridge between the two damaged spinal cord ends, reconnecting the neural tissue within the lesion site, hindering scar formation and the inflammatory process, reconstituting the conductive circuits of the nerve, reducing glutamate and calcium ions in cerebrospinal fluid, protecting neurons of spinal cord from apoptosis and finally enhancing locomotion recovery after spinal cord injury.[7] Neural tissue engineering studies have paid much attention to the essential parameters for biomaterial design such as biocompatibility, biodegradability, porosity and permeability.[8] Mechanical properties are especially crucial for successful transplantation of biomaterial, because the grafted biomaterial should not only be able to direct axonal regeneration prior to complete biodegradation, but also must be strong enough to bear normal forces from the spine and surrounding muscles.[9] The mechanical properties of biomaterials such as hydrogel scaffolds may influence the growth rates of regenerated nerve fibers.[10] The results of studies of neurite extension in 3D cultures reinforce that the mechanical properties of biomaterials play an important role in their ability to facilitate axonal regrowth.[10b,11] The fast biodegradation rate and low mechanical strength of some natural materials have limited their use as biomaterials, and modification by crosslinking techniques and optimization of the material composition are required to improve their mechanical properties and to enable tissue bridging and to achieve optimal results.[8,12]\nPoly (propylene fumarate) (PPF) polymer is a photo-crosslinkable or chemically cross-linkable biomaterial with biocompatibility and absorbability.[13] Synthetic PPF can be manufactured into various shapes and sizes and plays a therapeutic role when implanted in vivo either as an injectable biomaterial or in prefabricated scaffolds possessing high mechanical strength.[14] Porous PPF scaffolds have been extensively used in both bone and blood vessel regeneration tissue engineering studies, where they provide structural maintenance and suitably filling up tissue defects.[13,15] A recent study showed that PPF-based scaffolds can be coated with growth factors, including basic fibroblast growth factor (FGF-2), platelet-derived growth factor (PDGF-BB), or epidermal growth factor, which enhances the conventional application of PPF coated with bone morphogenetic protein alone.[16] There has been little research into the potential use of PPF-based biomaterial for CNS injury repair. However, in SPL201 cells, a conditionally immortalized Schwann cell precursor line that myelinates axons could be cultured on cross-linked PPF discs which did not cause cytotoxicity and significantly improved cell attachment and proliferation, suggesting that PPF-based biomaterial may be used for neural damage repair.[17]\nCollagen, with desirable attributes including low antigenicity, excellent biocompatibility and biodegradability when grafted in vivo, has been used widely as a biomaterial for spinal cord repair.[18] Linear ordered collagen scaffold is a nerve guidance material with excellent tissue compatibility and low antigenicity in vivo,[19] and when coated with myelin-associated inhibitor antibodies, it facilitates bridge establishment, synapse formation and locomotor enhancement.[19,20] Furthermore, 3D\ncollagen biomaterials combined with neurotrophic factors promoted neurite outgrowth in vitro and nerve fiber regrowth.[4b] Previous studies have shown that collagen biomaterial-based therapies for SCI induced numerous regenerative axons with myelination and functional recovery in canine models, and improvement of sensory function in lower limbs of humans without adverse events such as infection, allergic reaction, and aggravation of neurological status.[21]\nNeurotrophin-3 (NT3) has neuroprotective and neurotrophic roles in neurons and neural grafts, and promotes long-distance axonal extension and reconstitution of neural connectivity through the lesion site after severe SCI.[22] The results from several studies of CNS injury have indicated that effective controlled delivery of growth factor could limit the initial burst release of growth factors from biomaterials and enable the local delivery of growth factors with a sustained dosage over a prolonged time.[23] NT3 with an engineered collagen-binding domain (CBD-NT3) specifically binds to collagen biomaterials and retains high neurotrophic bioactivity when cultured with dorsal root ganglia neurons.[24] And collagen scaffolds exhibit controlled release of CBD-NT3 that promotes nerve fiber regeneration followed by hind limbs movement recovery after SCI.[24,25] In this study, we combined PPF with collagen biomaterial to establish biocompatible delivery system which may form a more stable spatial support without deformation in a short period and has higher mechanical properties than collagen alone. Combined with collagen and CBD-NT3, the functional parallel-aligned multichannel PPF scaffold was made for directing neural tissue regeneration across the lesion site through the porous structures, rebuilding bridge connectivity and accelerating axonal regrowth between the two spinal cord stumps after transection injury. The multichannel PPF scaffolds were produced by excimer laser photocuring,[26] specifically using the novel 3D printing methodology Mask Projection Excimer laser StereoLithography (MPExSL),[27] which is capable of high production yield of well-shaped 3D scaffolds with micrometer resolution. Within the combinatorial approach here adopted, collagen also acted as an effective cell attachment platform, along which neural lineage cells including neurons and oligodendrocytes could regenerate. Controlled-releasing CBD-NT3 loaded onto the collagen biomaterial provided continued neurotrophy and promoted survival of various types of functional neurons. This novel treatment strategy for SCI repair, combining biomaterials with growth factor, resulted in electrophysiological and locomotor improvements, and has potential for use in clinical therapy in the future."
    }, {
      "heading" : "2. Results",
      "text" : ""
    }, {
      "heading" : "2.1. Characterization of PPF-Collagen Scaffold with Collagen-Binding NT3 and Promotion of Neurite Outgrowth",
      "text" : "In Vitro by CBD-NT3\nThe prepared functional PPF scaffolds with regular lateral prisms consisted of an ≈4 mm deep × 5 mm diameter columnar structure with 24 equal-sized pores (Figure 1A). After the PPF scaffold was sectioned into pieces, it exhibited a uniform parallel-aligned porous structure and the pores could be\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (3 of 13)\nAdv. Healthcare Mater. 2018, 7, 1800315\nmean. Error bars indicate the SD from three different experiments (n = 4 scaffolds per group). * p < 0.05, ** p < 0.01.\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (4 of 13)\ndelivery platform combining PPF and collagen, which was predicted to be more stable than collagen biomaterial alone.\nBoth CBD-NT3 and NT3 provide neurotrophic stimulus for neurons, however, when tightly bound to collagen biomaterial, CBD-NT3 promotes survival of more neurons and elicits longer neurite outgrowth than NT3.[24] Isolated rat cerebellar granule neurons (CGNs) were cultured in 48-well plates with 40 × 10−9 m CBD-NT3 to confirm the bioactivity of CBD-NT3. In wells containing CBD-NT3, neurons exhibited neurite outgrowth, and under neurotrophic stimulus, these neurons extended significantly longer nerve fibers in wells with CBD-NT3 than in wells with PBS (p < 0.01, Figure 1D,E), verifying the bioactivity of CBD-NT3. Furthermore, we evaluated the release of CBD-NT3 from PPF and combinatorial scaffold in vitro by ELISA assay (Figure 1F). The released CBD-NT3 was detected at 1 h, 6 h, 12 h, 24 h, 3d, 7d after initial release. The results of accumulated concentration of released CBD-NT3 indicated that within short period (12 h) after initial release, most CBD-NT3 could be released rapidly from PPF scaffold. In contrast, CBD-NT3 loaded onto combinatorial scaffold exhibited more stable controlled releasing in vitro. It suggested that collagen significantly enhanced binding ability of CBD-NT3 to combinatorial scaffold and effectively achieved controlled releasing of CBD-NT3."
    }, {
      "heading" : "2.2. Transplantation of PPF-Collagen Scaffold with CBD-NT3 Reduced Glial and Fibrotic Scar Formation in the Lesion Center Following SCI",
      "text" : "In the rat complete transection SCI model, PPF scaffold, PPF-collagen scaffold or PPF-collagen scaffold loaded with CBD-NT3 were implanted into the injury sites, and SCI rats without scaffold implantation were used as a negative control (Figure 2A). At 12 weeks posttransplantation, the spinal cords of the four groups were harvested. Macroscopic observations indicated spinal cord tissue in the lesion site of control group was severely destroyed after injury and morphology of damaged tissue was clearly different form that of host tissues (Figure 2B). In contrast, there were good connectivity and integration of injured spinal cords with host tissues after treatment in the PPF+C group and PPF+C+NT3 group (Figure 2B).\nNext, we examined whether reduced scar formation resulted in the good spinal cord connectivity observed in the PPF+C+NT3 group compared with the other groups. Glial scars secrete a series of inhibitory molecules and are one of the main barriers to regeneration of damaged axons after CNS injury.[28] After transected spinal cord injury, control group exhibited obvious GFAPpositive astrocytic scar formation in the lesion area while there were fewer GFAP-positive areas in injury site of three scaffold groups (Figure S1A, Supporting Information). The number of GFAP-positive astrocyte in lesion center of control group were much greater than those of other groups (Figure S1B,C, Supporting Information, p < 0.01). There were least number of GFAP-positive astrocyte in lesion center of PPF+C+NT3 group (Figure S1B,C, Supporting Information, p < 0.01). Within the inhibitory microenvironment following SCI, one family of mole cules, the chondroitin sulfate proteoglycans (CSPGs), has a significant role in limiting the reparative response and CSPG\ndeposits are regarded as a substantial barrier.[4c] CS-56 staining was used to indicate CSPG expression at the lesion site. After transected SCI, the abundance of CS-56-positive signals at the lesion site in the control group was significantly higher than in the scaffold implantation groups (p < 0.01, Figure 2C,D). Among the three transplant therapy groups, the functional PPF-collagen scaffold with CBD-NT3 showed the greatest effect in reduction of CSPG deposits (p < 0.01, Figure 2D). All primary antibodies used in this study were listed in Table 1.\nFibrotic scarring, characterized by excessive deposition of extracellular matrix (ECM) molecules, is another important constituent of scar tissue that inhibits axons growing past the lesion site after SCI.[29] Furthermore, fibrotic scar is produced by fibroblasts that invade into the lesion area from adjacent meningeal and perivascular cells. The main extracellular matrices derived from those invading fibroblasts contain fibronection, laminin, and type IV collagen.[30] Given collagen was used as a major component of the combinatorial scaffolds, laminin was labeled to represent the accumulation of fibrotic scarring in the damaged area. Laminin-positive signals were detected at the lesion sites of rats in all groups, with the highest number of laminin-positive signals (81 ± 5.1) at the damage site of the control group (without any treatment). The number of laminin-positive signals in the control group was statistically significantly higher than those of all the other groups (p < 0.01, Figure 2E,F), and the laminin-positive signals were distributed across almost the whole injury site in the control group (Figure 2E). The PPF+C+NT3 group showed a significant reduction in the number of laminin-labeled cells (31 ± 3.9) compared with the other two groups with transplantation of PPF scaffolds (p < 0.01, Figure 2F). When combined with collagen, the grafted PPF scaffold exhibited significantly less laminin-positive fibrotic scar formation than PPF used alone (p < 0.05, Figure 2F). These results demonstrated that transplantation of a PPF scaffold promoted neural connectivity and integration of damaged tissues to host spinal cord with reduction of scar formation, which was enhanced when combined with collagen. The PPF scaffold combined with collagen and CBDNT3 prevented production of regeneration-inhibitory molecules under CBD-NT3 neurotrophic stimulation."
    }, {
      "heading" : "2.3. Treatment with PPF Combined with Collagen and CBD-NT3 Increased Production of Newly Generated and Mature Neurons and Facilitated axonal Regrowth at the Lesion Site",
      "text" : "We used β-III tubulin (Tuj-1), a marker of neuronal precursors, to examine the production of new neurons in the lesion area. The results showed that Tuj-1-positive neural tissue regenerated into the lesion site, and the regenerated neurons in the PPF+C+NT3 group effectively established a neuronal bridge between the two stumps following transection SCI (Figure 3A). We also found regrowth of several Tuj-1-positive tissue strips across the lesion area in the three groups in which functional PPF scaffold was implanted, illustrating guided nerve regeneration through the parallel-aligned multichannel structures of the porous PPF scaffold (Figure 3A). Furthermore, although Tuj-1-positive neurons were detected in all groups, the number of Tuj-1-positive neurons in the PPF+C+NT3 group was statistically significantly higher than those in the other three\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (5 of 13)\ngroups (p < 0.01, Figure 3B,C), while the number of Tuj-1-positive neurons in both the PPF and PPF+C groups were significantly higher than that of the control group (p < 0.05, Figure 3C). These results demonstrated that new neurons were generated in the lesion center following transplantation of PPF scaffolds after SCI, while the combinatorial treatment of PPF combined with collagen and CBD-NT3 exerted the greatest therapeutic effect.\nThe survival or generation of mature neurons was determined under conditions with or without PPF treatment. Rats of the PPF+C+NT3 group exhibited the largest number of Map2positive mature neurons at the middle of damage area compared with other groups (p < 0.01, Figure 3D,E). The PPF+C and PPF groups also exhibited promotion of neural regeneration, because the quantity of mature neurons in these two groups was also significantly greater than that of the control group (p < 0.01, Figure 3D,E). The curative effect of PPF combined with collagen was much greater than implantation of PPF alone, based on the statistically significant differences in the numbers\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (6 of 13)\nof mature neurons (p < 0.01, Figure 3E). These results indicated that PPF-based treatment could facilitate production of mature neurons, and when coated with CBD-NT3 that provides continuous neurotrophic effects and binding to collagen, the functional PPF scaffold biomaterial enhances survival of existing neurons and production of NSCs-derived mature neurons.\nThe immunofluorescence staining results also showed that neurofilament (NF)-positive signals were present in the lesion centers of rats in all groups after transected SCI (Figure 3F and Figure S2, Supporting Information). The PPF+C+NT3 group exhibited significantly more NF-positive signals than the other three groups, which indicated that it had the greatest amount of axonal regeneration (p < 0.01, Figure 3F,G), while the numbers of NF-positive signals in both the PPF and PPF+C group were higher than that of the control group, but were not significantly different from each other (p > 0.05, Figure 3G).\n2.4. Implantation of PPF Scaffold Combined with Collagen and CBD-NT3 into SCI Lesion Site Promoted Functional Axonal Regeneration Along with Myelination and Synapse Formation of Regenerated Axons\nAs observed above that we had found numerous regenerative axons in PPF+C+NT3 group, we further examined whether the numerous regenerative axons observed in the PPF+C+NT3 group were functional neurons. We detected that 5-HT-positive motor neurons had regenerated into the lesion area and co-labeled with NF-positive axons (Figure 4A,B), indicating the regrowth of serotonergic axons into the lesion site. Next, we used ChAT antibody to label spinal cord motor neurons and motor axons. ChATlabeled motor neurons were abundant in the injury center in the PPF+C+NT3 group after SCI and observation at higher magnification showed distinct colocalization of NF-positive axons with ChAT-positive neurons, indicating the regeneration of cholinergic neurons and axons (Figure 4C,D). Two types of sensory neurons, GABA-positive and TH-positive neurons, were also observed in the lesion area, and parts of these neurons showed double labeling with regenerated axons, indicating effective regeneration of gamma-aminobutyric acid-energetic and dopaminergic axons\n(Figure 4E–H). These findings suggested that the combination of PPF and collagen formed a stable delivery platform, which closely bound with and enabled controlled release of CBD-NT3 in vivo, and this combinatorial treatment consisting of a PPF scaffold with collagen and CBD-NT3 directed axonal regrowth and accelerated the regeneration of various functional neurons and axons into the injured area after severe SCI.\nTo confirm the remyelination, myelination and synapse formation of the abundant regenerated axons in the PPF+C+NT3 group, we double-stained for NF with myelin-associated glycoprotein (MAG) or synaptophysin (Syn). In the damage center, plentiful MAG-positive myelin co-localized with NF-positive axons and clear double labeling of regenerated axons and myelin was observed at higher magnification (Figure 4I,J). Additionally, Syn-positive signals also existed in the NF-positive axon-enriched area of the lesion site, and multiple synapse formations onto regenerated axons were detected at higher magnification (Figure 4K,L). These results demonstrated that there was not only abundant functional neuronal axon regrowth in the PPF+C+NT3 group, but also that these regenerated axons were effectively myelinated, accompanied by remyelination in the lesion site and the formation of synapses.\n2.5. Combinatorial Treatment Consisting of PPF Scaffold and Collagen Loaded with CBD-NT3 Induced Improvement of Electrophysiology and Locomotor Function Recovery After Transected Spinal Cord Injury\nTo measure enhancement of motor function, electrophysiological tests were carried out. Before SCI, animals receiving electrophysiological stimulation exhibited an average cortical motor-evoked potential (MEP) with a latent period of 2.6 ms and an amplitude of 6.95 mV, which was completely eliminated immediately after transected SCI (Figure 5A). At 12 weeks postinjury and transplant treatments, the latencies of MEPs in all groups were not restored to normal levels (p < 0.01, Figure 5A,B), however, the latencies of potentials in the PPF+C+NT3 group were shorter compared with those in the control group (p < 0.05, Figure 5B), suggesting an enhancement\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (7 of 13)\nof the latency. The amplitudes of MEPs in all groups did not recover to normal levels within the time period of the study, indicating severe damage of bioelectric conduction after transected SCI (p < 0.01, Figure 5A,C). Surprisingly, the amplitude in the PPF+C+NT3 group (20.7 ± 1.53 µV) was statistically significantly larger than those in the PPF+C (14.0 ± 2.83 µV), PPF (14.3 ± 1.41 µV) and control group (13.3 ± 0.58 µV) (p < 0.01, Figure 5C). These data suggest that the abundant myelination and synapse formation in regenerated axons described above contributes to reconstruction of neuronal relays in the lesion area, eventually resulting in electrophysiological improvement in animals in the PPF+C+NT3 group.\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (8 of 13)\nThe Basso–Beattie–Bresnahan (BBB) test was applied weekly to evaluate behavioral recovery after SCI. At 1 week after SCI, rats in all groups exhibited undetectable locomotion restoration with BBB scores of 0 (Figure 5D). During the period of 2–12 weeks postsurgery, rats in the PPF+C+NT3 group showed the greatest locomotion recovery, with BBB scores of 2–8, which were statistically significantly higher than those in the other three groups (p < 0.01, Figure 5D). BBB scores of rats in the PPF+C group were significantly higher than those in control group during 7–12 weeks post surgeries (p < 0.05, Figure 5D). BBB scores of the PPF+C+NT3 group plateaued at 10–12 weeks postinjury at levels of 8–9, meaning that there was at least sweeping of lower limbs with no weight support.[31] These findings indicated that the animals subjected to transected spinal\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (9 of 13)\ncord injury together with combinatorial treatment of functional PPF scaffold with collagen and CBD-NT3 showed restored effective hindlimb motor function, including significant movement ability in the three predominant joints."
    }, {
      "heading" : "3. Discussion",
      "text" : "Numerous complex biological processes contribute to the poor capacity for spontaneous regeneration after SCI. Formation of an inhibitory microenvironment following SCI results in failure of effective axonal regrowth even when there are small numbers of damaged axons caused by incomplete contusion.[32] In complete transection or spinal cord removal injury, the loss of all motor and sensory axonal tracts eliminates the possibility of translesion regeneration and restoration within a week, posing a significant challenge for treatment.[33] It is necessary to combine different biomaterials to integrate their respective advantages and provide multiple therapeutic effects.[34] In addition, a recent study reported that multichannel agarose scaffolds combined with brain-derived neurotrophic factor (BDNF) could induce motor axon regeneration into a severe injured spinal cord and organize linearly axons regrowth.[35] In the present study, we used a 3D printing approach based on stereolithography to fabricate parallel-aligned multichannel PPF scaffolds that enhanced the mechanical properties of a molecular delivery platform loaded with collagen. We confirmed the superior mechanical properties of the PPF scaffold compared with collagen. Specially, the uniform pores and parallel-aligned structure of the PPF scaffold provided guided channels for regeneration of neural tissues along the axial direction of spinal cord. Collagen biomaterials greatly filled into each channel and adhered to inner structures of pores in scaffold, promoting attachment of NSCs or new neurons and inducing axonal regeneration as regrowth-permissive matrix. A recent study reported an aid for peripheral nerve repair using\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (10 of 13)\nnerve conduits prepared by 405 nm micro-stereolithography.[36] However, they did not reported that these single-channel conduits possessed biodegradability. We are the first, to our knowledge, to have implanted a combinatorial scaffold comprising also multichannel biodegradable stereolithographycally 3D scaffolds for repair of CNS injury. A previous research using similar technology in present study has reported the degradation of PPF material in vitro.[37] The weight of PPF material decreased by about 30% after degrading for 90 d.[37] The data indicates that PPF scaffold is a kind of degradable biomaterial in vitro. However, the degradation in PBS is significantly different from body fluid in SCI sites.[37] In our present study, we found the most of this biodegradable PPF scaffold degraded at 12 weeks post-surgery. And we further weighed these small PPF residues (11.8 ± 2.8 mg) compared with mass of 1-mm PPF scaffold (70 ± 2.6mg). Mass decay of PPF scaffold ranged from 79.20% to 87.10%.\nWe have also focused on the utilization of a CBD to enhance the collagen-binding ability of growth factors. CBD-fused proteins can bind tightly to native and insoluble collagen, limiting the likelihood of them being washed away or diluted and preventing their rapid diffusion in the extracellular fluids, thus enabling enhanced aggregation onto the collagen-based biomaterial.[38] Moreover, CBD-fusion has been reported to have no impact on the bioactivity of growth factors.[39] In fact, CBDfused growth factors have been shown to elicit greater biological effects than native growth factors in vitro, enabling collagenbased biomaterials to be developed as sustained-release delivery system.[4b,25,39] CBD-NT3 is bioactive and promotes neurite outgrowth in vitro, and controlled release of CBD-NT3 coated on a delivery platform exhibits continual neurotrophic effects and contributes to an improved microenvironment following SCI for 2–3 d,[40] assisting neural regeneration in the lesion center. In this study, we found that within short period (12 h) after initial release, plentiful CBD-NT3 could be released rapidly from PPF scaffold. Combinatorial scaffold exhibited more stably controlled releasing for CBD-NT3 loaded in vitro. We speculate the release of CBD-NT3 in the SCI sites might be rapid than in PBS, because the sustained flow of cerebrospinal fluid and the degradation of scaffold. But the release rate of CBD-NT3 in PPF+C scaffold might still be much slower than in PPF (Figure 1F).\nEpendymal cells of the central canal in the adult spinal cord are considered to be potential endogenous NSCs, and they are able to be induced to proliferate and differentiate after traumatic SCI.[41] Previous studies have revealed robust proliferation of activated endogenous NSCs in the lesion center and initiation of migration of these NSCs from the central canal within 3 d after SCI.[42] In the present study, there were likely abundances of endogenous NSCs in uninjured segments adjacent to lesion site in short term after transected spinal cord injury. At the lesion site, we observed the highest number of newly generated neurons in the PPF+C+NT3 group, suggesting that controlled release of CBD-NT3 could offer neurotrophy and neuroprotection to the host spinal cord neurons, sparing endogenous NSCs after SCI and likely further directing neural differentiation of NSCs within 2–3 d postsurgery. Moreover, in all three PPF treatment groups, Tuj-1-positive signals across the lesion area demonstrated that parts of likely activated endogenous NSCs and sparing NSCs might be able to attach to the porous biomaterials\nand proliferate, migrate and differentiate along the pores or channels, potentially contributed to regeneration of neural tissue bridges that connect the two transected spinal cord ends. Actually, part of Tuj-1-positive neuron might be deprived from other sources, such as survived or uninjured host neurons. Additional production of sprouting from surviving neurons in the spinal cord induced with treatment was another important reason for effective neural regeneration. Collagen enhanced attachment of NSCs or neurons and CBD-NT3 further promoted surviving of host neural tissues and regeneration of neural tissues across the lesion site. The maximum number of mature neurons was also observed in the injury center of the PPF+C+NT3 group, which could be explained by effects of CBD-NT3 on survival of likely endogenous NSC-derived neurons and of host sparing neurons. Surprisingly, the combinatorial treatment involving PPF, collagen and CBD-NT3 also resulted in a decrease in deposition of inhibitory molecules and reduction of scar tissue formation (Figure 2C,E), resulting in improved neural connection and integration between damaged and host spinal cord (Figure 2B). These results indicate that coated onto collagen, the tissue regeneration-permissive matrix, neurotrophic CBD-NT3 contributes to provide a supportive microenvironment for neural regeneration and further vastly amplifies therapeutic effect of PPF+C+NT3 treatment, supporting the idea that optimal repair of SCI is likely to involve combined treatment strategies.\nIn addition to finding higher numbers of regenerated axons in the PPF+C+NT3 group than in the other groups, we confirmed functional neuronal regeneration and colocalization with regenerated axons in the lesion area. These findings indicated that the addition of CBD-NT3 soon after injury clearly enhanced the neural regeneration response. The generation and regrowth of various types of functional motor and sensory neurons in the PPF+C+NT3 group corresponded with improved functional assessment outcomes (Figure 5D). Plentiful regrowth of axons into the lesion site represented potential reestablishment of neural connections. The remyelination in axon-abundant areas and myelination of newly generated axons that benefited bioelectric conduction, together with detectable synapse formation on the regenerated axons, indicating potential rebuilding of neural relays. Regrowth of axons across lesion area and reestablishment of neural relays potentially underlied the improvement of electrophysical function with restored latency and enhanced amplitude of MEP in PPF+C+NT3 group (Figure 4I,J and 5B,C).[43] However, a limitation of our study was that we did not perform retrograde or anterograde tracing which might better evaluate regrowth of axonal tracts across lesion site and reestablishment of neural relays.\nA recent study has revealed numerous and long-distance axonal regeneration beyond the transected spinal cord injury site with effective myelination, synapse formation and expression of neurotransmitters resulting in significant improvement of electrophysiological and locomotor recovery,[22a] demonstrating the formation of new functional neural relays to support functional restoration. In the present study, remyelination and synapse formation in the regenerated axon-abundant area of the PPF+C+NT3 group was associated with eventual improvement of electrophysiology and locomotion. These functional recoveries indicated the potential establishment of new neuronal circuits.\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (11 of 13)"
    }, {
      "heading" : "4. Conclusion",
      "text" : "In this study, we prepared parallel-aligned multichannel PPF with high mechanical strength and successfully combined this with collagen biomaterial, creating a novel molecule delivery platform with stable spatial support in vivo. When coated with bioactive CBD-NT3 (PPF+C+NT3) and implanted into transected spinal cord, the treatment showed effective neurotrophy and protection of neural tissues, inducing axonal regrowth and functional neuron regeneration. PPF+C+NT3 also promoted myelination and synapse formation of these regenerated axons. The porous structure of the delivery platform provided attachment and channels for host endogenous NSCs, which achieved migration, proliferation and differentiation under this improved microenvironment, along with reduction of CSPG deposits and fibrotic scarring, contributing to neuronal regeneration. The anatomical outcomes corresponded with the enhancement of functional assays that showed significantly better electrophysiological and locomotor recovery in rats receiving treatment combining PPF with collagen and CBD-NT3 that could be beneficial to clinical research in the future."
    }, {
      "heading" : "5. Experimental Section",
      "text" : "Ethics: All experimental procedures were performed in accordance with Chinese Ministry of Public Health (CMPH) Guide and the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health.\nPreparation of Poly(Propylene Fumarate) Scaffold: To synthesize PPF, fumaric acid was heated in access of propylene glycol at 145 °C, with overhead mechanical stirrer under chemical hood, a Barrette trap was connected beneath the condenser and water was collected as by-product.[44] After 17 h of reaction the temperature was increased to 185 °C for 5 h and then cooled to room temperature. The PPF was then dissolved in dichloromethane, repeated for three times. The synthesized PPF was blended with diethyl fumarate (DEF) at a ratio of 70:30 (PPF:DEF), and with the photoinitiator bis-acyl phosphine oxide Irgacure 819 at a concentration of 1.0% wt/wt. The photoinitiator was first dissolved in ethanol, then after complete dissolution DEF was added, and finally PPF was added. The solution was then stirred under hood for 3 d. The 3D multichannel scaffolds were produced using MPExSL following the procedure presented in.[27,45] Briefly, the surface of the photocurable PPF-based resin is irradiated with 308 nm light pulses from an excimer XeCl laser (COMPexPro-110, Coherent) using a mask projection system. The resin surface is cured only on the irradiated part, thus creating a solid layer with 500 µm channels. The layer thickness is defined by the number of laser pulses applied, and in the present case was 120 µm. The 3D scaffolds were created layer-bylayer, i.e., recasting fresh resin on top of the cured layer and repeating the laser irradiation, with 20 micron overlap between adjacent layers. The final size of the cylindrical scaffolds is 5 mm in diameter and few mm long.\nCombining of Collagen onto PPF Scaffolds: Prepared porous PPF biomaterials were steeped in 75% alcohol for 24 h and then washed 10 times with sterile water. The PPF biomaterials were placed on a sterile surface and gently cut into several uniform 1-mm thick pieces. After drying, one piece was placed into each well of a 96-well plate, and the remaining pieces were stored in sterile tubes. Each PPF-containing well was then filled by injection of prefabricated collagen biomaterial prepared as previously described,[18] and the plate was centrifuged for 10 min at 5000 rpm. Plates were frozen at −80 °C for 48 h followed by 24 h of freeze-drying. The dried and stable combinatorial biomaterials were cut into 1 mm thick pieces and stored in sterile tubes.\nTest of Mechanical Properties: For measurement of mechanical properties, 1 mm thick pieces of PPF or collagen were placed in a materials-testing machine (Instron 3365) with 30 mm diameter plates at room temperature. The mechanical sensor was used with a 10-N load cell and the upper plate was lowered at a rate of 3 mm min−1. Compressive strain and compressive pressure data were collected.\nProtein Bioactivity Assessment: CBD-NT3 was purified as previously described.[24,25] Briefly, the coding sequence of CBD, TKKTLRT, was fused to human NT3, into which a His-linker and pET-28a were inserted, producing engineered CBD-NT3. Then CGNs were cultured with CBD-NT3 to estimate its bioactivity. Briefly, CGNs were isolated from 5 d old Sprague Dawley rats and the cerebellums were dissected in trypsin solution (0.25% in PBS buffer) and seeded on 48-well plates with 40 × 10−9 m CBD-NT3 or PBS as a control. After culture for 24 h, neurons were fixed in 4% paraformaldehyde at 4 °C for 20 min, and incubated in DPBS containing 5% bovine serum albumin with 0.1% Triton X-100 for 1 h at RT. The neurons were incubated with βIII tubulin primary antibody overnight at 4 °C and incubated with corresponding secondary antibody for 1 h at RT. Cell nuclei were then stained with Hoechst 33342 and neurite outgrowth of CGNs was visualized under a Zeiss 200 fluorescence microscope (Carl Zeiss). The mean length of the neurite outgrowths per field was assessed using the accessory software of AxioVision (Zeiss Microscopy GmbH, Germany).\nELISA Assay: Four 1 mm PPF scaffolds and four 1 mm combinatorial scaffolds were loaded with 5ug CBD-NT3 and 200 µL PBS was added to detect CBD-NT3 releasing from the scaffold at room temperature. The released CBD-NT3 was detected at 1 h, 6 h, 12 h, 24 h, 3 d, 7 d after initial release, respectively. All samples were measured with Human NT-3 DuoSet Elisa plate (R&D System, USA). The results were quantified at 450 nm using an ELISA reader (Molecular Devices, USA).\nSurgery Processing: Animals were anesthetized by intraperitoneal injection of sodium pentobarbital. A 1.5 cm midline incision was made on the back to expose the T8–T10 vertebrae. Laminectomy was performed at the T9 vertebral level using a #11 surgical blade. A 1 mm long transection of the T9 spinal cord was made and the lesion site was irrigated with normal saline followed by control of bleeding with gelatin sponge. Rats were randomly divided into four groups: (1) control group, no treatment after 1 mm long transected spinal cord injury; 2) PPF group, a 1 mm thick piece of PPF prepared as described above was transplanted into the transection site immediately after SCI; 3) PPF + Collagen (PPF + C) group, a 1 mm thick piece of combinatorial biomaterial containing PPF and collagen bound with 20µL of PBS was implanted into the lesion site after SCI; 4) PPF + Collagen + CBD-NT3 (PPF + C + NT3) group, a piece of combinatorial biomaterial loaded with 20 µL of CBD-NT3 (5 µg) was implanted into the transected lesion gap after SCI. The muscle and skin layers were then closed with sutures.\nElectrophysiology: Twelve weeks after surgery, animals in each group were intraperitoneally anesthetized with sodium pentobarbital and cortical motor-evoked potentials (cMEPs) were measured using the Keypoint bichannel-evoked potential/electromyography system (9033A07, Dantec Company, Copenhagen, Denmark) as previously described.[46] Briefly, two steel stimulating electrodes were inserted into the cranial surface of the motor cortex behind the anterior fontanel. Two recording electrodes and one reference electrode were inserted into the contralateral gastrocnemius muscle at a depth of 2 mm and dorsal skin at a depth of 3 mm. Then, a cMEP was recorded following a single stimulation with intensity of 45 mA.\nBehavioral Assessment: The BBB 21-point open field locomotion rating scale was applied weekly following surgeries.[31] Hind limb movements of each animal were assessed by two independent observers blinded to group identity.\nMass Decay Test of Scaffold: PPF scaffolds were weighed and four animals underwent operations with PPF as described above. At 12 weeks post surgeries, several remanant little PPF residues were taken out from each animal carefully. Obvious connnective tissues on PPF were cleared away by using microforceps and PPF residues were added with 100 U mL−1 collagenase (Invitrogen, USA) for 4 h at 37 °C to clear the rest of connnective tissues. Washed with PBS for 5 times, PPF residues were dried at room temperature and weighed.\nAdv. Healthcare Mater. 2018, 7, 1800315\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (12 of 13)\nAdv. Healthcare Mater. 2018, 7, 1800315\nStatistical Analysis: All statistical analyses were conducted using the statistical software SPSS19.0. Data were presented as means ± standard deviations. Multiple group comparisons were performed using one-way analysis of variance. Two-group comparisons were performed by applying Student’s t-test. Statistically significant differences were represented as * p-value < 0.05 and ** p-value < 0.01.\nSupporting Information Supporting Information is available from the Wiley Online Library or from the author."
    }, {
      "heading" : "Acknowledgements",
      "text" : "X.C. and Y.Z. contributed equally to this work. This work was supported by grants from the National Key R&D Program of China (2017YFA0104704 and 2016YFC1101500), Key Research Program of the Chinese Academy of Sciences (Grant No. ZDRW-ZS-2016-2), Youth Innovation Promotion Association CAS (2015077 and 2016096), and the European Union (FP7-NMP-2013-EU-China call, grant agreement no. 604263 – NEUROSCAFFOLDS). F.B.’s corresponding email address was amended on July 25, 2018, after initial online publication."
    }, {
      "heading" : "Conflict of Interest",
      "text" : "The authors declare no conflict of interest."
    }, {
      "heading" : "Keywords",
      "text" : "collagen, neural regeneration, poly(propylene fumarate) scaffolds, spinal cord injury, stereolithography\nReceived: March 25, 2018 Revised: May 11, 2018 Published online: June 19, 2018\n[1] T. Hagg, M. Oudega, J. Neurotrauma 2006, 23, 264. [2] a) L. L. Jones, M. Oudega, M. B. Bunge, M. H. Tuszynski,\nJ. Physiol. 2001, 533, 83; b) K. Kadoya, S. Tsukada, P. Lu, G. Coppola, D. Geschwind, M. T. Filbin, A. Blesch, M. H. Tuszynski, Neuroendocrinology 2009, 64, 165. [3] M. B. Bunge, Neuroscientist 2001, 7, 325. [4] a) M. T. Fitch, J. Silver, Exp. Neurol. 2008, 209, 294; b) X. Li, J. Han,\nY. Zhao, W. Ding, J. Wei, J. Li, S. Han, X. Shang, B. Wang, B. Chen, Z. Xiao, J. Dai, Acta Biomater. 2016, 30, 233; c) J. R. Siebert, A. Conta Steencken, D. J. Osterhout, BioMed Res. Int. 2014, 2014, 845323. [5] T. B. Jones, E. E. McDaniel, P. G. Popovich, Curr. Pharm. Des. 2005, 11, 1223. [6] C. Profyris, S. S. Cheema, D. Zang, M. F. Azari, K. Boyle, S. Petratos, Neurobiol. Dis. 2004, 15, 415. [7] a) A. E. Haggerty, M. Oudega, Neurosci. Bull. 2013, 29, 445; b) M. Wang, P. Zhai, X. Chen, D. J. Schreyer, X. Sun, F. Cui, Tissue Eng., Part B 2011, 17, 177; c) B. Q. Lai, M. T. Che, B. L. Du, X. Zeng, Y. H. Ma, B. Feng, X. C. Qiu, K. Zhang, S. Liu, H. Y. Shen, J. L. Wu, E. A. Ling, Y. S. Zeng, Biomaterials 2016, 109, 40; d) D. Liu, J. Chen, T. Jiang, W. Li, Y. Huang, X. Lu, Z. Liu, W. Zhang, Z. Zhou, Q. Ding, H. A. Santos, G. Yin, J. Fan, Adv. Mater. 2018, 30, e1706032; e) D. Liu, T. Jiang, W. Cai, J. Chen, H. Zhang, S. Hietala, H. A. Santos, G. Yin, J. Fan, Adv. Healthcare Mater. 2016, 5, 1513.\n[8] S. Kubinova, E. Sykova, Regener. Med. 2012, 7, 207. [9] B. Shrestha, K. Coykendall, Y. Li, A. Moon, P. Priyadarshani, L. Yao,\nStem Cell Res. Ther. 2014, 5, 91. [10] a) R. K. Willits, S. L. Skornia, J. Biomater. Sci., Polym. Ed. 2004, 15,\n1521; b) T. W. Carone, J. M. Hasenwinkel, J. Biomed. Mater. Res., Part B 2006, 78, 274. [11] A. P. Balgude, X. Yu, A. Szymanski, R. V. Bellamkonda, Biomaterials 2001, 22, 1077. [12] M. Tsintou, K. Dalamagkas, A. M. Seifalian, Neural Regener. Res. 2015, 10, 726. [13] R. Mishra, B. M. Roux, M. Posukonis, E. Bodamer, E. M. Brey, J. P. Fisher, D. Dean, Biomaterials 2016, 77, 255. [14] a) C. C. Wu, L. H. Hsu, S. Sumi, K. C. Yang, S. H. Yang, J. Biomed. Mater. Res., Part B 2017, 105, 2232; b) J. M. Walker, E. Bodamer, O. Krebs, Y. Luo, A. Kleinfehn, M. L. Becker, D. Dean, Biomacromolecules 2017, 18, 1419; c) D. Dean, W. Jonathan, A. Siblani, M. O. Wang, K. Kim, A. G. Mikos, J. P. Fisher, Virtual Phys. Prototyping 2012, 7, 13. [15] M. Dadsetan, T. Guda, M. B. Runge, D. Mijares, R. Z. LeGeros, J. P. LeGeros, D. T. Silliman, L. Lu, J. C. Wenke, P. R. Brown Baer, M. J. Yaszemski, Acta Biomater. 2015, 18, 9. [16] R. Mishra, R. S. Sefcik, T. J. Bishop, S. M. Montelone, N. Crouser, J. F. Welter, A. I. Caplan, D. Dean, Tissue Eng., Part C 2016, 22, 904. [17] S. Wang, D. H. Kempen, N. K. Simha, J. L. Lewis, A. J. Windebank, M. J. Yaszemski, L. Lu, Biomacromolecules 2008, 9, 1229. [18] X. Li, S. Liu, Y. Zhao, J. Li, W. Ding, S. Han, B. Chen, Z. Xiao, J. Dai, Adv. Funct. Mater. 2016, 26, 5835. [19] Q. Han, W. Jin, Z. Xiao, H. Ni, J. Wang, J. Kong, J. Wu, W. Liang, L. Chen, Y. Zhao, B. Chen, J. Dai, Biomaterials 2010, 31, 9212. [20] X. Li, Z. Xiao, J. Han, L. Chen, H. Xiao, F. Ma, X. Hou, X. Li, J. Sun, W. Ding, Y. Zhao, B. Chen, J. Dai, Biomaterials 2013, 34, 5107. [21] a) S. Han, B. Wang, W. Jin, Z. Xiao, X. Li, W. Ding, M. Kapur, B. Chen, B. Yuan, T. Zhu, H. Wang, J. Wang, Q. Dong, W. Liang, J. Dai, Biomaterials 2015, 41, 89; b) Z. Xiao, F. Tang, J. Tang, H. Yang, Y. Zhao, B. Chen, S. Han, N. Wang, X. Li, S. Cheng, G. Han, C. Zhao, X. Yang, Y. Chen, Q. Shi, S. Hou, S. Zhang, J. Dai, Sci. China: Life Sci. 2016, 59, 647; c) Y. Zhao, F. Tang, Z. Xiao, G. Han, N. Wang, N. Yin, B. Chen, X. Jiang, C. Yun, W. Han, C. Zhao, S. Cheng, S. Zhang, J. Dai, Cell Transplant. 2017, 26, 891. [22] a) P. Lu, Y. Wang, L. Graham, K. McHale, M. Gao, D. Wu, J. Brock, A. Blesch, E. S. Rosenzweig, L. A. Havton, B. Zheng, J. M. Conner, M. Marsala, M. H. Tuszynski, Cell 2012, 150, 1264; b) K. Kadoya, P. Lu, K. Nguyen, C. Lee-Kubli, H. Kumamaru, L. Yao, J. Knackert, G. Poplawski, J. N. Dulin, H. Strobl, Y. Takashima, J. Biane, J. Conner, S. C. Zhang, M. H. Tuszynski, Nat. Med. 2016, 22, 479. [23] a) S. J. Taylor, S. E. Sakiyama-Elbert, J. Controlled Release 2006, 116, 204; b) N. K. Mohtaram, A. Montgomery, S. M. Willerth, Biomed. Mater. 2013, 8, 022001. [24] J. Fan, Z. Xiao, H. Zhang, B. Chen, G. Tang, X. Hou, W. Ding, B. Wang, P. Zhang, J. Dai, R. Xu, J. Neurotrauma 2010, 27, 1671. [25] X. Li, J. Han, Y. Zhao, W. Ding, J. Wei, S. Han, X. Shang, B. Wang, B. Chen, Z. Xiao, J. Dai, ACS Appl. Mater. Interfaces 2015, 7, 13960. [26] a) F. Brandi, F. Anjum, L. Ceseracciu, A. C. Barone, A. Athanassiou, J. Micromech. Microeng. 2011, 21, 054007; b) S. Beke, F. Anjum, H. Tsushima, L. Ceseracciu, E. Chieregatti, A. Diaspro, A. Athanassiou, F. Brandi, J. R. Soc., Interface 2012, 9, 3017; c) S. Beke, F. Anjum, L. Ceseracciu, I. Romano, A. Athanassiou, A. Diaspro, F. Brandi, Laser Phys. 2013, 23, 035602. [27] S. Beke, B. Farkas, I. Romano, F. Brandi, Opt. Mater. Express 2014, 4, 2032. [28] J. Silver, J. H. Miller, Nat. Rev. Neurosci. 2004, 5, 146. [29] a) C. Soderblom, X. Luo, E. Blumenthal, E. Bray, K. Lyapichev,\nJ. Ramos, V. Krishnan, C. Lai-Hsu, K. K. Park, P. Tsoulfas, J. K. Lee, J. Neurosci. 2013, 33, 13882; b) A. E. Haggerty, M. M. Marlow, M. Oudega, Neurosci. Lett. 2017, 652, 50.\n© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800315 (13 of 13)\n[30] H. Kawano, J. Kimura-Kuroda, Y. Komuta, N. Yoshioka, H. P. Li, K. Kawamura, Y. Li, G. Raisman, Cell Tissue Res. 2012, 349, 169. [31] D. M. Basso, M. S. Beattie, J. C. Bresnahan, Exp. Neurol. 1996, 139, 244. [32] P. Assinck, G. J. Duncan, B. J. Hilton, J. R. Plemel, W. Tetzlaff, Nat.\nNeurosci. 2017, 20, 637. [33] J. R. Siebert, A. M. Eade, D. J. Osterhout, BioMed Res. Int. 2015,\n2015, 752572. [34] a) B. Xu, Y. Zhao, Z. Xiao, B. Wang, H. Liang, X. Li, Y. Fang,\nS. Han, X. Li, C. Fan, J. Dai, Adv. Healthcare Mater. 2017, 6; b) S. M. Amr, A. Gouda, W. T. Koptan, A. A. Galal, D. S. Abdel-Fattah, L. A. Rashed, H. M. Atta, M. T. Abdel-Aziz, J. Spinal Cord Med. 2014, 37, 54. [35] M. Gao, P. Lu, B. Bednark, D. Lynam, J. M. Conner, J. Sakamoto, M. H. Tuszynski, Biomaterials 2013, 34, 1529. [36] C. J. Pateman, A. J. Harding, A. Glen, C. S. Taylor, C. R. Christmas, P. P. Robinson, S. Rimmer, F. M. Boissonade, F. Claeyssens, J. W. Haycock, Biomaterials 2015, 49, 77. [37] P. Ferraro, S. Scaglione, R. Barenghi, S. Beke, L. Ceseracciu, I. Romano, F. Sbrana, P. Stagnaro, F. Brandi, M. Vassalli, M. Ritsch-Marte, S. Grilli, D. Stifter, Proc. SPIE 2013, 8792, 87920H. [38] a) B. Chen, H. Lin, J. Wang, Y. Zhao, B. Wang, W. Zhao, W. Sun, J. Dai, Biomaterials 2007, 28, 1027; b) W. Zhao, B. Chen, X. Li, H. Lin, W. Sun, Y. Zhao, B. Wang, Y. Zhao, Q. Han, J. Dai, J. Biomed.\nMater. Res., Part A 2007, 82, 630; c) Q. Shi, W. Gao, X. Han, X. Zhu, J. Sun, F. Xie, X. Hou, H. Yang, J. Dai, L. Chen, Sci. China: Life Sci. 2014, 57, 232. [39] H. Lin, B. Chen, W. Sun, W. Zhao, Y. Zhao, J. Dai, Biomaterials 2006, 27, 5708. [40] W. Liang, Q. Han, W. Jin, Z. Xiao, J. Huang, H. Ni, B. Chen, J. Kong, J. Wu, J. Dai, Biomaterials 2010, 31, 8634. [41] a) L. K. Hamilton, M. K. Truong, M. R. Bednarczyk, A. Aumont, K. J. Fernandes, Neuroscience 2009, 164, 1044; b) S. Lacroix, L. K. Hamilton, A. Vaugeois, S. Beaudoin, C. Breault-Dugas, I. Pineau, S. A. Levesque, C. A. Gregoire, K. J. Fernandes, PloS One 2014, 9, e85916. [42] a) Y. Qin, W. Zhang, P. Yang, J. Neurosci. Res. 2015, 93, 391; b) X. Li, Y. Zhao, S. Cheng, S. Han, M. Shu, B. Chen, X. Chen, F. Tang, N. Wang, Y. Tu, B. Wang, Z. Xiao, S. Zhang, J. Dai, Biomaterials 2017, 137, 73. [43] Z. Xiao, B. Chen, J. Dai, J. Spine 2016, S7, 005. [44] P. X. Lan, J. W. Lee, Y. J. Seol, D. W. Cho, J. Mater. Sci.: Mater. Med.\n2009, 20, 271. [45] B. Farkas, S. Dante, F. Brandi, Nanotechnology 2016, 28,\n034001. [46] N. Wang, Z. Xiao, Y. Zhao, B. Wang, X. Li, J. Li, J. Dai, J. Tissue Eng.\nRegener. Med. 2018, 12, e1154.\nAdv. Healthcare Mater. 2018, 7, 1800315"
    } ],
    "references" : [ {
      "title" : "Opt",
      "author" : [ "S. Beke", "B. Farkas", "I. Romano", "F. Brandi" ],
      "venue" : "Mater. Express 2014, 4",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2032
    }, {
      "title" : "BioMed Res",
      "author" : [ "J.R. Siebert", "A.M. Eade", "D.J. Osterhout" ],
      "venue" : "Int. 2015",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2015
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "The multichannel PPF scaffolds were produced by excimer laser photocuring,[26] specifically using the novel 3D printing methodology Mask Projection Excimer laser StereoLithography (MPExSL),[27] which is capable of high production yield of well-shaped 3D scaffolds with micrometer resolution.",
      "startOffset" : 189,
      "endOffset" : 193
    }, {
      "referenceID" : 1,
      "context" : "[32] In complete transection or spinal cord removal injury, the loss of all motor and sensory axonal tracts eliminates the possibility of translesion regeneration and restoration within a week, posing a significant challenge for treatment.[33] It is necessary to combine different biomaterials to integrate their respective advantages and provide multiple therapeutic effects.",
      "startOffset" : 239,
      "endOffset" : 243
    }, {
      "referenceID" : 0,
      "context" : "The 3D multichannel scaffolds were produced using MPExSL following the procedure presented in.[27,45] Briefly, the surface of the photocurable PPF-based resin is irradiated with 308 nm light pulses from an excimer XeCl laser (COMPexPro-110, Coherent) using a mask projection system.",
      "startOffset" : 94,
      "endOffset" : 101
    } ],
    "year" : 2018,
    "abstractText" : "Spinal cord injury (SCI) is a severe and irreversible central nervous system (CNS) injury with varying degrees of damage and loss of motor and sensory functions below the injury level.[1] Numerous mechanisms underlie the deficient axonal regrowth and poor functional recovery that occur postSCI, including an absence of neurotrophic factors to protect neurons and to stimulate intrinsic neuronal regeneration-related responses,[2] the lack of growth-permissive substrates to support axon elongation through the lesion area,[3] the production of various myelin-associated and extracellular matrix-derived inhibitory molecules including Nogo, oligodendrocyte myelin glycoprotein (OMgp), and chondroitin sulfate proteoglycans (CSPGs),[4] and the occurrence of a range of secondary effects including vascular damage, scar formation, and inflammation.[4a,5] Given that even apparently minor displacement of spinal tissue can result in severing of axons and loss of function, the Many factors contribute to the poor axonal regrowth and ineffective functional recovery after spinal cord injury (SCI). Biomaterials have been used for SCI repair by promoting bridge formation and reconnecting the neural tissue at the lesion site. The mechanical properties of biomaterials are critical for successful design to ensure the stable support as soon as possible when compressed by the surrounding spine and musculature. Poly(propylene fumarate) (PPF) scaffolds with high mechanical strength have been shown to provide firm spatial maintenance and to promote repair of tissue defects. A multichannel PPF scaffold is combined with collagen biomaterial to build a novel biocompatible delivery system coated with neurotrophin-3 containing an engineered collagen-binding domain (CBD-NT3). The parallel-aligned multichannel structure of PPF scaffolds guide the direction of neural tissue regeneration across the lesion site and promote reestablishment of bridge connectivity. The combinatorial treatment consisting of PPF and collagen loaded with CBD-NT3 improves the inhibitory microenvironment, facilitates axonal and neuronal regeneration, survival of various types of functional neurons and remyelination and synapse formation of regenerated axons following SCI. This novel treatment strategy for SCI repair effectively promotes neural tissue regeneration after transected spinal injury by providing a regrowth-supportive microenvironment and eventually induces functional improvement. Poly(Propylene Fumarate) Scaffolds",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}